Home > Formulary : Paediatric > Paediatric Chapters > 5. Infections >
BNSSG Paediatric Joint Formulary
5.3 Fungal infection
Last edited: 14-02-2024
5.3 Fungal infection
First line drugs |
Second line drugs |
Specialist drugs |
Secondary care drugs |
Antifungals
Terbinafine (oral) (TLS Green)
Alternatives:
Griseofulvin (oral) (TLS Blue)
Echinocandin Antifungals
Micafungin (parenteral) (TLS Red)
- Secondary care restricted, see local guidelines
Caspofungin (parenteral) (TLS Red)
- Secondary care restricted, see local guidelines
Fluorinated Pyrimidine Antifungals
Flucytosine (oral & parenteral) (TLS Red)
- Secondary care restricted, see local guidelines
Polyene Antifungals
Liposomal amphotericin (parenteral) (TLS Red)
- Restricted, see local guidelines
- The National Patient Safety Agency has advised all healthcare staff involved in the use of intravenous amphotericin of the potentially lethal results if non-lipid and lipid formulations of the drug are confused
- Caution: double check
Triazole Antifungals
Fluconazole (oral) (TLS Green)
Alternatives:
Itraconazole (oral) (TLS Blue)
Fluconazole (parenteral) (TLS Red)
- Restricted, see local guidelines
Voriconazole (oral & parenteral) (TLS Red)
- Secondary care restricted, see local guidelines
Posaconazole (oral) (TLS Red)
- Secondary care restricted, see local guidelines
5.3.1 Pneumocystis pneumonia
Co-trimoxazole (parenteral & oral) (TLS Red)
- Secondary care restricted, see local guidelines
Atovaquone (oral) (TLS Red)
- Secondary care restricted, see local guidelines
Dapsone (oral) (TLS Red)
- Secondary care restricted, see local guidelines
Pentamidine (parenteral & nebulised) (TLS Red)
- Secondary care restricted, see local guidelines
Primaquine (oral) (unlicensed) (TLS Red)
- Secondary care restricted, see local guidelines